GV — Genomic Vision SA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Genomic Vision SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.9 | -4.61 | -5.18 | -4.97 | -6.79 |
| Depreciation | |||||
| Non-Cash Items | — | 0.007 | — | 0.204 | 0.888 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.152 | -0.603 | 0.923 | 0.017 | 0.806 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.59 | -5.13 | -3.67 | -4.52 | -4.41 |
| Capital Expenditures | -0.062 | -0.012 | -0.144 | -0.099 | -0.102 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.001 | -0.014 | — | 0.073 | -0.167 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.063 | -0.026 | -0.144 | -0.026 | -0.269 |
| Financing Cash Flow Items | 0.3 | 0 | — | — | -0.171 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.8 | 3.06 | 4.72 | 4.84 | 3.15 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.15 | -2.09 | 0.908 | 0.296 | -1.53 |